Stay updated on SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page.

Latest updates to the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page
- CheckyesterdayChange DetectedThe sponsor changed from Sage Therapeutics to Biogen. Biogen is now listed as sponsor and responsible party on the study page.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check30 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference6%

- Check37 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference1.0%

- Check51 days agoChange DetectedThe page revision has been updated from v3.0.1 to v3.0.2, indicating a minor content update. A 'Back to Top' link was removed, a small user interface change.SummaryDifference0.4%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.4%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of new drug information related to Zuranolone and a focus on drug safety, while removing various location details and previous drug classifications.SummaryDifference4%

Stay in the know with updates to SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page.